Skip to main content
124I-MIBG PET/CT to Monitor Metastatic Disease in Children with Relapsed Neuroblastoma.
Validation of Postinduction Curie Scores in High-Risk Neuroblastoma: A Children's Oncology Group and SIOPEN Group Report on SIOPEN/HR-NBL1.
Semiquantitative mIBG scoring as a prognostic indicator in patients with stage 4 neuroblastoma: a report from the Children's oncology group.
Dose escalation study of no-carrier-added 131I-metaiodobenzylguanidine for relapsed or refractory neuroblastoma: new approaches to neuroblastoma therapy consortium trial.
Correlation of tumor and whole-body dosimetry with tumor response and toxicity in refractory neuroblastoma treated with (131)I-MIBG.
Neuroblastoma imaging using a combined CT scanner-scintillation camera and 131I-MIBG.
Optimized diagnostic strategy for neuroblastoma in opsoclonus-myoclonus.